Table 3 Complexity parameters for each group of plans (average and range)
|  | a - Clinical | b - Clinical + TO | c - RP_1 | d - RP_1 + TO | e - RP_TO | f - RP_ TO+ |
|---|---|---|---|---|---|---|
ALPO (cm) p < 0.05 | 3.37 (2.54–5.40) c,d,e,f | 3.39 (2.46–5.99) d,e,f | 3.16 (2.42–4.83) a,e,f | 3.04 (2.45–5.34) a,b,e,f | 2.72 (1.89–4.19) a,b,c,d,f | 2.89 (2.16–4.60) a,b,c,d,e |
MF p < 0.05 | 0.477 (0.347–0.574) d,e,f | 0.467 (0.345–0.562) d,e,f | 0.461 (0.390–0.503) d,e,f | 0.430 (0.361–0.519) a,b,c,e | 0.405 (0.366–0.446) a,b,c,d | 0.414 (0.379–0.464) a,b,c |
MU p < 0.05 | 489 (399–652) d,e,f | 501 (407–662) d,e,f | 501 (453–568) d,e,f | 541 (456–647) a,b,c,e | 571 (497–622) a,b,c,d | 560 (478–603) a,b,c |